Evidence Question
Do SGLT2 Inhibitors lower HbA1c?
Related to: SGLT2 InhibitorsShort answer
SGLT2 Inhibitors may lower HbA1c.
Evidence at a glance
- Evidence strength
- Strong Evidence
- Supporting research
- 23 studys
- Randomized trials
- 22 trials
- Evidence updated
- Feb 2026
Why do we say this?
Across 23 studies, including 22 randomized trials, findings are consistent and showed an effect on HbA1c with SGLT2 Inhibitors.
Explore the evidence
Supporting research
23 published studys
- Empagliflozin improves nighttime glycemia in type 1 diabetes
- Empagliflozin reduces body fluid volume in type 2 diabetes patients
- Empagliflozin improves heart function in type 2 diabetes patients
- Adding medications improves blood sugar control in diabetes patients.
- Intermittent Fasting Diet Improves Glycemic Control in Type 2 Diabetes